Krilogy Financial LLC lifted its position in shares of The Allstate Corporation (NYSE:ALL – Free Report) by 125.4% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,138 shares of the insurance provider’s stock after buying an additional 2,859 shares during the period. Krilogy Financial LLC’s holdings in Allstate were worth $1,099,000 as of its most recent SEC filing.
A number of other hedge funds also recently bought and sold shares of ALL. Total Clarity Wealth Management Inc. boosted its stake in Allstate by 1.5% in the first quarter. Total Clarity Wealth Management Inc. now owns 5,169 shares of the insurance provider’s stock worth $1,072,000 after buying an additional 76 shares in the last quarter. Signal Advisors Wealth LLC raised its stake in shares of Allstate by 2.6% during the first quarter. Signal Advisors Wealth LLC now owns 3,202 shares of the insurance provider’s stock worth $664,000 after acquiring an additional 81 shares in the last quarter. Athena Wealth Management LLC bought a new stake in shares of Allstate in the 1st quarter worth approximately $1,115,000. Discipline Wealth Solutions LLC bought a new stake in shares of Allstate in the 1st quarter worth approximately $340,000. Finally, AdvisorNet Financial Inc boosted its stake in shares of Allstate by 1.7% in the 1st quarter. AdvisorNet Financial Inc now owns 5,575 shares of the insurance provider’s stock valued at $1,156,000 after purchasing an additional 92 shares in the last quarter. Institutional investors own 76.47% of the company’s stock.
Allstate Stock Down 0.8%
Shares of NYSE ALL opened at $231.74 on Friday. The company has a quick ratio of 0.36, a current ratio of 0.36 and a debt-to-equity ratio of 0.25. The Allstate Corporation has a 52 week low of $188.08 and a 52 week high of $237.10. The firm’s fifty day moving average is $217.25 and its 200 day moving average is $209.89. The company has a market cap of $59.65 billion, a price-to-earnings ratio of 5.11, a PEG ratio of 0.41 and a beta of 0.18.
Allstate Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 1st. Stockholders of record on Monday, June 1st will be paid a dividend of $1.08 per share. This represents a $4.32 annualized dividend and a dividend yield of 1.9%. The ex-dividend date of this dividend is Monday, June 1st. Allstate’s dividend payout ratio is 9.53%.
Insider Activity
In other news, insider Mark Q. Prindiville sold 1,550 shares of the stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $216.27, for a total transaction of $335,218.50. Following the completion of the sale, the insider directly owned 27,558 shares in the company, valued at approximately $5,959,968.66. This represents a 5.32% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Andrea Redmond sold 2,225 shares of the firm’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $202.91, for a total value of $451,474.75. Following the completion of the sale, the director directly owned 2,225 shares in the company, valued at $451,474.75. The trade was a 50.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 22,353 shares of company stock valued at $4,851,560. Insiders own 1.55% of the company’s stock.
Analysts Set New Price Targets
Several research firms recently commented on ALL. Wall Street Zen lowered shares of Allstate from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Wells Fargo & Company upped their price target on shares of Allstate from $229.00 to $243.00 and gave the company an “equal weight” rating in a research report on Wednesday, May 6th. Barclays raised their price objective on Allstate from $207.00 to $208.00 and gave the company an “underweight” rating in a research note on Wednesday, April 8th. Keefe, Bruyette & Woods downgraded Allstate from an “outperform” rating to a “market perform” rating and decreased their price objective for the stock from $266.00 to $242.00 in a report on Monday, June 8th. Finally, The Goldman Sachs Group reissued a “neutral” rating and issued a $231.00 target price on shares of Allstate in a research note on Thursday, March 5th. Three equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, ten have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $240.33.
Get Our Latest Stock Analysis on ALL
Allstate Profile
Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.
The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.
Read More
- Five stocks we like better than Allstate
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
